Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Rad Laboratories 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 USA

www.bio-rad.com P: 510-724-7000 F: 510-741-5817

Description:

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.

Key Statistics

Overview:

Market Capitalization, $K 7,988,745
Enterprise Value, $K 8,784,465
Shares Outstanding, K 28,518
Annual Sales, $ 2,671 M
Annual Net Income, $ -637,320 K
Last Quarter Sales, $ 681,180 K
Last Quarter Net Income, $ 349,710 K
EBIT, $ 337,800 K
EBITDA, $ 337,800 K
60-Month Beta 0.87
% of Insider Shareholders 17.50%
% of Institutional Shareholders 65.24%
Float, K 23,527
% Float 82.50%
Short Volume Ratio 0.79

Growth:

1-Year Return -38.94%
3-Year Return -54.73%
5-Year Return -7.48%
5-Year Revenue Growth 16.68%
5-Year Earnings Growth 101.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 3.10 on 02/15/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm 11.77
EPS Growth vs. Prev Qtr 33.05%
EPS Growth vs. Prev Year -6.34%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BIO Ratios

Ratio
Price/Earnings ttm 23.77
Price/Earnings forward 26.98
Price/Earnings to Growth N/A
Return-on-Equity % 3.90%
Return-on-Assets % 2.77%
Profit Margin % -23.86%
Debt/Equity 0.14
Price/Sales 2.99
Price/Cash Flow 23.21
Price/Book 0.92
Book Value/Share 306.49
Interest Coverage -16.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar